000 | 01854 a2200529 4500 | ||
---|---|---|---|
005 | 20250514220837.0 | ||
264 | 0 | _c20050412 | |
008 | 200504s 0 0 eng d | ||
022 | _a1525-4135 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVincent, Thierry | |
245 | 0 | 0 |
_aT-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists. _h[electronic resource] |
260 |
_bJournal of acquired immune deficiency syndromes (1999) _cMar 2005 |
||
300 |
_a305-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aCCR5 Receptor Antagonists |
650 | 0 | 4 |
_aCD4 Antigens _xanalysis |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCD8 Antigens _xanalysis |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHLA-DR Antigens _xanalysis |
650 | 0 | 4 |
_aHepacivirus _xisolation & purification |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver _xpathology |
650 | 0 | 4 |
_aLiver Cirrhosis _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aReceptors, CCR5 _xanalysis |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aTransaminases _xblood |
650 | 0 | 4 | _aViral Load |
700 | 1 | _aPortales, Pierre | |
700 | 1 | _aBaillat, Vincent | |
700 | 1 | _ade Boever, Corinne Merle | |
700 | 1 | _aLe Moing, Vincent | |
700 | 1 | _aVidal, Michèle | |
700 | 1 | _aDucos, Jacques | |
700 | 1 | _aClot, Jacques | |
700 | 1 | _aReynes, Jacques | |
700 | 1 | _aCorbeau, Pierre | |
773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 38 _gno. 3 _gp. 305-9 |
|
999 |
_c15409745 _d15409745 |